Other News To Note
Friday, August 12, 2011
Neoprobe Corp., of Dublin, Ohio, submitted a new drug application to the FDA for Lymphoseek (tilmanocept) for use in intraoperative lymphatic mapping. The procedure, which identifies and biopsies lymph nodes draining the area around a tumor, is used primarily in melanoma and breast cancer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.